The Selenium-Iodine-Kidney Axis: A Proposed Integrative Pathway for Renal Oxidative Defense

Chronic kidney disease affects approximately 850 million people worldwide and is driven in large part by mitochondrial dysfunction in renal proximal tubular cells, where oxidative stress overwhelms local antioxidant defense capacity. This paper proposes that selenium adequacy functions as the rate-limiting upstream variable governing renal oxidative defense through two simultaneous and mechanistically distinct pathways: direct selenoprotein-mediated antioxidant defense within renal tubular cells, principally via glutathione peroxidase 3 (GPx3); and indirect defense through thyroid hormone-mediated regulation of renal perfusion, wherein selenium-dependent deiodinase enzymes govern the conversion of inactive T4 to the active hormone T3. We further propose that iodine's potential contribution to renal health is selenium-gated and cannot be evaluated in isolation, and that coenzyme Q10 provides a complementary direct mitochondrial protection layer. All claims represent hypothesis-level proposed mechanistic relationships requiring prospective clinical confirmation.